Trexquant Investment LP Forma Therapeutics Holdings, Inc. Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $3,182 - $9,047	-447 Reduced 1.52%	28,868 $576,000
Q2 2022 Aug 11, 2022	BUY	$5.1 - $10.0 $149,506 - $293,150	29,315 New	29,315 $202,000
Q1 2022 May 13, 2022	SELL	$8.34 - $14.69 $220,301 - $388,036	-26,415 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $237,850 - $435,301	17,489 Added 195.93%	26,415 $376,000
Q3 2021 Nov 12, 2021	BUY	$21.22 - $25.7 $189,409 - $229,398	8,926 New	8,926 $207,000
Q1 2021 May 13, 2021	SELL	$24.58 - $42.82 $269,347 - $469,221	-10,958 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$34.9 - $51.08 $382,434 - $559,734	10,958 New	10,958 $382,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.